Author Question: If a pharmaceutical company wished to design a drug to maintain low blood sugar (Read 600 times)

TI

  • Sr. Member
  • ****
  • Posts: 434
If a pharmaceutical company wished to design a drug to maintain low blood sugar levels, one approach might be to design a compound
A) that activates epinephrine receptors.
B) that increases cAMP production in liver cells.
C) to block G protein activity in liver cells.
D) that increases phosphorylase activity.
E) that keeps sugar molecules from crossing the plasma membrane of liver cells.



coco

  • Hero Member
  • *****
  • Posts: 739
In class, we found it was C. Good luck with the rest.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question

TI

  • Sr. Member
  • ****
  • Posts: 434

 

Did you know?

The first war in which wide-scale use of anesthetics occurred was the Civil War, and 80% of all wounds were in the extremities.

Did you know?

The first oncogene was discovered in 1970 and was termed SRC (pronounced "SARK").

Did you know?

If you use artificial sweeteners, such as cyclamates, your eyes may be more sensitive to light. Other factors that will make your eyes more sensitive to light include use of antibiotics, oral contraceptives, hypertension medications, diuretics, and antidiabetic medications.

Did you know?

More than 50% of American adults have oral herpes, which is commonly known as "cold sores" or "fever blisters." The herpes virus can be active on the skin surface without showing any signs or causing any symptoms.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library